NDC 73377-094 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-094
- Package NDCs from labels
- 73377-094-01, 73377-094-02, 73377-094-03, 73377-094-04, 73377-094-05, 73377-094-06, 73377-094-07
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-094-01 | Losartan Potassium | 100 g in 1 JAR | POWDER | 100 | 7 | |
| 73377-094-02 | Losartan Potassium | 25 g in 1 JAR | POWDER | 25 | 7 | |
| 73377-094-03 | Losartan Potassium | 1000 g in 1 JAR | POWDER | 1000 | 7 | |
| 73377-094-04 | Losartan Potassium | 97 g in 1 JAR | POWDER | 97 | 7 | |
| 73377-094-05 | Losartan Potassium | 80 g in 1 JAR | POWDER | 80 | 7 | |
| 73377-094-06 | Losartan Potassium | 500 g in 1 JAR | POWDER | 500 | 7 | |
| 73377-094-07 | Losartan Potassium | 1500 g in 1 JAR | POWDER | 1500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 03c0ec8d-9daf-43e8-8a4e-a2ddc3573ca7 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 23117ad8-39ad-44f2-b7d2-2dbc8edc9734 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | d7b61f05-871d-4ffd-ab9b-9a3e60fd34c4 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | be99cc03-ea65-4b17-bd9e-df7ae4307778 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 59801c48-2af7-4967-ae70-99f865551a7a | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 1d6712a3-bfb3-4081-b8f6-6057eb4baa27 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 05818573-0b40-4731-a9d1-152c708905bf | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d838e918-2463-79f6-e053-2a95a90a948d | 2026-03-05 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 4d60e755-40a6-4187-b09e-e55c735945aa | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | ba76eb91-bea6-4e37-e053-2a95a90a065a | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 372ba4ad-26ca-4675-8475-4b664fbecba9 | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | dc9512cf-db66-40e9-afcb-1d6a722772e8 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 3ee3240f-78a1-4fd2-a779-c22693711721 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | f29cc61a-afba-4ecb-8043-5f103872f1ae | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 2c810cde-fa40-4772-806e-c31809e6bbfb | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 5ec290f4-bf21-4c5b-a576-8eb2bd6bd379 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium | LOSARTAN POTASSIUM | Novadoz Pharmaceuticals LLC | 5edb843a-66ed-4950-9ed0-393e6a5d7c99 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | Strides Pharma Science Limited | a8817f22-8478-49b9-8354-ab27ca222c6b | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| COZAAR | LOSARTAN POTASSIUM | Organon LLC | 9949448f-c3b9-44ee-94ed-c1aca8c90f39 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Coupler LLC | 44fd38d2-cb8b-d0e8-e063-6294a90a994e | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.